EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Elexacaftor/Tezacaftor/Ivacaftor Effect on Bone Density and Body Composition: A Retrospective Analysis

Susanne Ursula Trost iD, Tasma Harindhanavudhi, Qi Wang, Anvitha Ankireddypalli, Azmi Simrah, Sreekant Avula, Amir Moheet

Pediatric Pulmonology · 2025

DOI: 10.1002/ppul.71280 ↗

At a glance

Journal article in Pediatric Pulmonology, 2025. Written by Susanne Ursula Trost and 6 co-authors. Institution: Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, University of Minnesota, Minneapolis, Minnesota, USA. Major MEDLINE topics: Bone Density, Cystic Fibrosis, Body Composition, Aminophenols. Cited 4 times so far (Crossref); 34 references. The full text is freely available (open access, CC BY 4.0). Funded by: The authors received no specific funding for this work..

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

The approval of cystic fibrosis transmembrane conductance regulator modulators elexacaftor/tezacaftor/ivacaftor (ETI), has significantly improved pulmonary function for people with cystic fibrosis (pwCF). However, the effects on CF‐related bone disease and body composition remain unclear.

Methods

This retrospective real‐world study examined adults with CF who received ETI treatment. Bone density and body composition were measured via dual‐energy X‐ray absorptiometry (DXA) 1.8 (SD 0.7) years before (preDXA) and 1.5 (SD 0.4) years after ETI initiation (postDXA1). In a subgroup, measurements were also available 4 (SD 0.6) years after initiation (postDXA2).

Results

The study included 74 pwCF, of whom 42% were female, with an average age of 38.9 (SD 9.3) years at ETI initiation. Bone density decreased significantly at the spine ( p = 0.02), left hip ( p < 0.01), and right hip ( p < 0.01) from pre‐ to postDXA1. No significant change in bone density was observed when comparing postDXA1 to postDXA2. Body composition analysis revealed significant increases in weight in both females ( p < 0.01) and males ( p < 0.01), as well as increases in fat mass in females ( p < 0.01) and males ( p < 0.01), without significant changes in lean mass ( p = 0.4).

Conclusions

Bone density declined significantly during the study period, with the most pronounced decline occurring in the first 1.5 years after ETI initiation. However, this decline appeared to stabilize in participants with longer follow‐up at 4 years post‐ETI treatment, suggesting potential bone‐protective effects with prolonged therapy. Body weight and fat mass increased early after ETI initiation, suggesting metabolic changes accompanying CFTR modulation.

Subjects

MeSH terms (MEDLINE)

Bone DensityCystic FibrosisBody CompositionAminophenolsBenzodioxolesQuinolonesIndolesPyridinesPyrrolidinesPyrazolesHumansFemaleRetrospective StudiesMaleAdultAbsorptiometry, PhotonDrug CombinationsMiddle AgedCystic Fibrosis Transmembrane Conductance Regulator

Author keywords

body compositionbone densitybone healthcystic fibrosiselexacaftor/tezacaftor/ivacaftorfat mass

Substances

AminophenolsBenzodioxolesQuinolonesivacaftorelexacaftorIndolestezacaftorDrug CombinationsPyridinesPyrrolidines

Authors and institutions

  • Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, University of Minnesota, Minneapolis, Minnesota, USA.
  • Clinical and Transitional Science Institute, University of Minnesota, Minneapolis, Minnesota, USA.

ORCID profiles: Susanne Ursula Trost

Funding

  • The authors received no specific funding for this work.

Cite

APA

Trost, S. U., Harindhanavudhi, T., Wang, Q., Ankireddypalli, A., Simrah, A., Avula, S., & Moheet, A. (2025). Elexacaftor/Tezacaftor/Ivacaftor Effect on Bone Density and Body Composition: A Retrospective Analysis. Pediatric Pulmonology. https://doi.org/10.1002/ppul.71280

Vancouver

Trost SU, Harindhanavudhi T, Wang Q, Ankireddypalli A, Simrah A, Avula S, et al. Elexacaftor/Tezacaftor/Ivacaftor Effect on Bone Density and Body Composition: A Retrospective Analysis. Pediatric Pulmonology. 2025. doi:10.1002/ppul.71280

BibTeX
@article{Trost2025,
  author = {Trost, Susanne Ursula and Harindhanavudhi, Tasma and Wang, Qi and Ankireddypalli, Anvitha and Simrah, Azmi and Avula, Sreekant and Moheet, Amir},
  title = {Elexacaftor/Tezacaftor/Ivacaftor Effect on Bone Density and Body Composition: A Retrospective Analysis},
  journal = {Pediatric Pulmonology},
  year = {2025},
  doi = {10.1002/ppul.71280}
}
Start for free →